Use of atypical antipsychotics in the elderly.
暂无分享,去创建一个
[1] Jeffrey Cummings,et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. , 2008, The Journal of clinical psychiatry.
[2] S. Gauthier,et al. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis , 2008, International journal of geriatric psychiatry.
[3] D. Jeste,et al. ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia , 2008, Neuropsychopharmacology.
[4] A. Egberts,et al. Antipsychotic Drug Use and Risk of Pneumonia in Elderly People , 2008, Journal of the American Geriatrics Society.
[5] J. Mintzer,et al. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[6] M. Valenstein,et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. , 2007, The American journal of psychiatry.
[7] P. Tariot,et al. Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study. , 2007, Current Alzheimer research.
[8] N. Herrmann,et al. A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.
[9] Daniel Weintraub,et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. , 2006, The New England journal of medicine.
[10] J. Avorn,et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. , 2005, The New England journal of medicine.
[11] L. Schneider,et al. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[12] Lon S Schneider,et al. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. , 2005, JAMA.
[13] P. Deyn,et al. Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone , 2005, Clinical Neurology and Neurosurgery.
[14] J. Cummings,et al. Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies , 2006, Nature Reviews Drug Discovery.